| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 83 |
| 1 | LAMIVUDINE ORAL | 83 |
| 2 | EMTRICITABINE | 55 |
| 3 | ZIDOVUDINE | 55 |
| 4 | RITONAVIR | 39 |
| 5 | RITONAVIR 100 MG | 39 |
| 6 | RALTEGRAVIR | 30 |
| 7 | ATAZANAVIR | 29 |
| 8 | ABACAVIR SULFATE | 24 |
| 9 | DARUNAVIR | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MARAVIROC | 15 | 0.0065 |
| 1 | RALTEGRAVIR | 30 | 0.0057 |
| 2 | ZIDOVUDINE | 55 | 0.0053 |
| 3 | DORAVIRINE | 4 | 0.0051 |
| 4 | DARUNAVIR 600 MG | 21 | 0.0034 |
| 5 | LAMIVUDINE | 83 | 0.0033 |
| 6 | RITONAVIR 100 MG | 39 | 0.0026 |
| 7 | ABACAVIR SULFATE | 24 | 0.0025 |
| 8 | ATAZANAVIR | 29 | 0.0020 |
| 9 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 16 | 0.0019 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 15 | 0.0065 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 83 | 0.0017 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 121 | 0.0011 |
| 3 | Protease Inhibitor [EPC] | 46 | 0.0010 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 17 | 0.0007 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 40 | 0.0007 |
| 6 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 7 | Antimalarial [EPC] | 1 | 0.0001 |
| 8 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |